T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis

Clinical Science

Volumn 129, Issue 4, 2015, Pages 291-303

  Ruocco, Gabriella ^a   Rossi, Silvia ^b   Motta, Caterina ^b   Macchiarulo, Giulia ^b   Barbieri, Francesca ^b   De Bardi, Marco ^a   Borsellino, Giovanna ^a   Finardi, Annamaria ^c   Grasso, Maria Grazia ^a   Ruggieri, Serena ^d   Gasperini, Claudio ^d   Furlan, Roberto ^c   Centonze, Diego ^a,b   Battistini, Luca ^a   Volpe, Elisabetta ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Cerebrospinal fluid; Dendritic cells; Interleukin 17; Interleukin 9; Multiple sclerosis; T helper cells

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 9; RESIQUIMOD; STAT1 PROTEIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; AUTACOID; IL9 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; STAT1 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MALE; MULTIPLE SCLEROSIS; MYELOID DENDRITIC CELL; NERVE DEGENERATION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TH17 CELL; TH9 CELL; CASE CONTROL STUDY; CELL COMMUNICATION; CELL CULTURE; CLASSIFICATION; DENDRITIC CELL; DRUG EFFECTS; HELPER CELL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TIME;

ADULT; CASE-CONTROL STUDIES; CELL COMMUNICATION; CELLS, CULTURED; DENDRITIC CELLS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; IMIDAZOLES; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-17; INTERLEUKIN-9; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHENOTYPE; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84938507306     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20140608     Document Type: Article

References (75)

1. Goverman, J. (2009) Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407.
2. + T cells. Science 327, 1098-1102.
3. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. and Coffman, R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
4. Coffman, R.L. (2006) Origins of the T(H)1-T(H)2 model: a personal perspective. Nat. Immunol. 7, 539-541.
5. Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y., Hood, L., Zhu, Z., Tian, Q. and Dong, C. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141.
6. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132.
7. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H. et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119, 3573-3585.
8. O'Garra, A. and Vieira, P. (2007) T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7, 425-428.
9. Ito, T., Yang, M., Wang, Y.H., Lande, R., Gregorio, J., Perng, O.A., Qin, X.F., Liu, Y.J. and Gilliet, M. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115.
10. + regulatory T cells. Int. Immunol. 16, 249-256.
11. Bettelli, E., Oukka, M. and Kuchroo, V.K. (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350.
12. Panitch, H.S., Hirsch, R.L., Haley, A.S. and Johnson, K.P. (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1, 893-895.
13. Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M.T., Pedemonte, E., Noonan, D., Albini, A., Bernardi, G. et al. (2003) Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73, 584-590.
14. Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J. and Tolosa, E. (2009) Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329-3341.
15. + T cells in the patients with neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 261, 87-91.
16. Rolla, S., Bardina, V., De Mercanti, S., Quaglino, P., Palma, R.D., Gned, D., Brusa, D., Durelli, L., Novelli, F. and Clerico, M. (2014) Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β. J. Leukoc. Biol. 96, 1155-1164.
17. Rissoan, M.C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y.J. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
18. Liu, Y.J. (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306.
19. Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L. et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292-302.
20. Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S., Hupé, P., Barillot, E. and Soumelis, V. (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9, 650-657.
21. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
22. Rossi, S., Studer, V., Motta, C., Germani, G., Macchiarulo, G., Buttari, F., Mancino, R., Castelli, M., De Chiara, V., Weiss, S. et al. (2014) Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. J. Neuroinflammation 11, 32.
23. Roxburgh, R.H., Seaman, S.R., Masterman, T., Hensiek, A.E., Sawcer, S.J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E. et al. (2005) Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64, 1144-1151.
24. Rossi, S., Mancino, R., Bergami, A., Mori, F., Castelli, M., De Chiara, V., Studer, V., Mataluni, G., Sancesario, G., Parisi, V. et al. (2011) Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis. Mult. Scler. 17, 1301-1312.
25. Rossi, S., Furlan, R., De Chiara, V., Motta, C., Studer, V., Mori, F., Musella, A., Bergami, A., Muzio, L., Bernardi, G. et al. (2012) Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann. Neurol. 71, 76-83.
26. Ebers, G.C., Heigenhauser, L., Daumer, M., Lederer, C. and Noseworthy, J.H. (2008) Disability as an outcome in MS clinical trials. Neurology 71, 624-631.
27. Meyer-Moock, S., Feng, Y.S., Maeurer, M., Dippel, F.W. and Kohlmann, T. (2014) Systematic literature review and validity evaluation of the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 14, 58.
28. Amato, M.P. and Ponziani, G. (1999) Quantification of impairment in MS: discussion of the scales in use. Mult. Scler. 5, 216-219.
29. Freedman, M.S. (2011) Improving long-term follow-up studies of immunomodulatory therapies. Neurology 76, S35-38.
30. Weinstock-Guttman, B., Galetta, S.L., Giovannoni, G., Havrdova, E., Hutchinson, M., Kappos, L., O'Connor, P.W., Phillips, J.T., Polman, C., Stuart, W.H. et al. (2012) Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. J. Neurol. 259, 898-905.
31. Paolicelli, D., D'Onghia, M., Pellegrini, F., Direnzo, V., Iaffaldano, P., Lavolpe, V. and Trojano, M. (2013) The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study. J. Neurol. 260, 1562-1568.
32. Rossi, S., Studer, V., Moscatelli, A., Motta, C., Coghe, G., Fenu, G., Caillier, S., Buttari, F., Mori, F., Barbieri, F. et al. (2013) Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. PLoS One 8, e67357.
33. Kuhle, J., Malmestrom, C., Axelsson, M., Plattner, K., Yaldizli, O., Derfuss, T., Giovannoni, G., Kappos, L. and Lycke, J. (2013) Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Acta Neurol. Scand. 128, e33-e36.
34. Frohman, E.M., Fujimoto, J.G., Frohman, T.C., Calabresi, P.A., Cutter, G. and Balcer, L.J. (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nature clinical practice. Neurology 4, 664-675.
35. Barkhof, F., Calabresi, P.A., Miller, D.H. and Reingold, S.C. (2009) Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat. Rev. Neurol. 5, 256-266.
36. Burkholder, B.M., Osborne, B., Loguidice, M.J., Bisker, E., Frohman, T.C., Conger, A., Ratchford, J.N., Warner, C., Markowitz, C.E., Jacobs, D.A. et al. (2009) Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch. Neurol. 66, 1366-1372.
37. Elyaman, W., Bradshaw, E.M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.C. et al. (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 106, 12885-12890.
38. Ivanov, II, Zhou, L. and Littman, D.R. (2007) Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 19, 409-417.
39. Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T.W., Kamradt, T. and Lohoff, M. (2007) The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958-966.
40. Knoops, L. and Renauld, J.C. (2004) IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22, 207-215.
41. Chen, Z., Laurence, A., Kanno, Y., Pacher-Zavisin, M., Zhu, B.M., Tato, C., Yoshimura, A., Hennighausen, L. and O'Shea, J.J. (2006) Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. U.S.A. 103, 8137-8142.
42. Wei, L., Laurence, A., Elias, K.M. and O'Shea, J.J. (2007) IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282, 34605-34610.
43. Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L. et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381.
44. Yang, X.P., Ghoreschi, K., Steward-Tharp, S.M., Rodriguez-Canales, J., Zhu, J., Grainger, J.R., Hirahara, K., Sun, H.W., Wei, L., Vahedi, G. et al. (2011) Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247-254.
45. Iwasaki, A. and Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995.
46. Kattah, M.G., Wong, M.T., Yocum, M.D. and Utz, P.J. (2008) Cytokines secreted in response to toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum. 58, 1619-1629.
47. Lombardi, V., Van Overtvelt, L., Horiot, S. and Moingeon, P. (2009) Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J. Immunol. 182, 3372-3379.
48. Manel, N., Unutmaz, D. and Littman, D. (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9, 641-649.
49. Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A. and Sallusto, F. (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942-949.
50. Zielinski, C.E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A. and Sallusto, F. (2012) Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484, 514-518.
51. Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V. and Amigorena, S. (2013) Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336-348.
52. Chiurchiu, V., Cencioni, M.T., Bisicchia, E., De Bardi, M., Gasperini, C., Borsellino, G., Centonze, D., Battistini, L. and Maccarrone, M. (2013) Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis. Ann. Neurol. 73, 626-636.
53. Gilliet, M. and Liu, Y.J. (2002) Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum. Immunol. 63, 1149-1155.
54. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F. (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 10, 857-863.
55. Froidure, A., Shen, C., Gras, D., Van Snick, J., Chanez, P. and Pilette, C. (2014) Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 69, 1068-1076.
56. Ronnblom, L. and Alm, G.V. (2001) A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194, F59-F63.
57. Nestle, F.O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.J. and Gilliet, M. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202, 135-143.
58. Gottenberg, J.E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C. et al. (2006) Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 103, 2770-2775.
59. Lande, R., Gafa, V., Serafini, B., Giacomini, E., Visconti, A., Remoli, M.E., Severa, M., Parmentier, M., Ristori, G., Salvetti, M. et al. (2008) Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 67, 388-401.
60. Dodd, J.S., Lum, E., Goulding, J., Muir, R., Van Snick, J. and Openshaw, P.J. (2009) IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J. Immunol. 183, 7006-7013.
61. Fallon, P.G., Smith, P., Richardson, E.J., Jones, F.J., Faulkner, H.C., Van Snick, J., Renauld, J.C., Grencis, R.K. and Dunne, D.W. (2000) Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect. Immun. 68, 6005-6011.
62. Faulkner, H., Humphreys, N., Renauld, J.C., Van Snick, J. and Grencis, R. (1997) Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 27, 2536-2540.
63. Faulkner, H., Renauld, J.C., Van Snick, J. and Grencis, R.K. (1998) Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66, 3832-3840.
64. Forbes, E.E., Groschwitz, K., Abonia, J.P., Brandt, E.B., Cohen, E., Blanchard, C., Ahrens, R., Seidu, L., McKenzie, A., Strait, R. et al. (2008) IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913.
65. Gessner, A., Blum, H. and Rollinghoff, M. (1993) Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189, 419-435.
66. Knoops, L., Louahed, J., Van Snick, J. and Renauld, J.C. (2005) IL-9 promotes but is not necessary for systemic anaphylaxis. J. Immunol. 175, 335-341.
67. Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J. et al. (2012) Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122, 4160-4171.
68. Osterfeld, H., Ahrens, R., Strait, R., Finkelman, F.D., Renauld, J.C. and Hogan, S.P. (2010) Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J. Allergy Clin. Immunol. 125, 469-476.
69. Shimbara, A., Christodoulopoulos, P., Soussi-Gounni, A., Olivenstein, R., Nakamura, Y., Levitt, R.C., Nicolaides, N.C., Holroyd, K.J., Tsicopoulos, A., Lafitte, J.J. et al. (2000) IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105, 108-115.
70. Nowak, E.C., Weaver, C.T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A.J., Kasper, L.H. and Noelle, R.J. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. J, Exp. Med. 206, 1653-1660.
71. Jager, A., Dardalhon, V., Sobel, R.A., Bettelli, E. and Kuchroo, V.K. (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177.
72. Singh, T.P., Schon, M.P., Wallbrecht, K., Gruber-Wackernagel, A., Wang, X.J. and Wolf, P. (2013) Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One 8, e51752.
73. Leng, R.X., Pan, H.F., Ye, D.Q. and Xu, Y. (2012) Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus. Am. J. Clin. Exp. Immunol. 1, 28-32.
74. Ouyang, H., Shi, Y., Liu, Z., Feng, S., Li, L., Su, N., Lu, Y. and Kong, S. (2013) Increased interleukin9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. Mol. Med. Rep. 7, 1031-1037.
75. Matsushita, T., Tateishi, T., Isobe, N., Yonekawa, T., Yamasaki, R., Matsuse, D., Murai, H. and Kira, J. (2013) Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One 8, e61835.